Effects of mild perioperative hypothermia on cellular immune function in patients undergoing surgery for rectal cancer
10.3760/cma.j.issn.0254-1416.2012.01.004
- VernacularTitle:轻度低温对直肠癌根治术患者细胞免疫功能的影响
- Author:
Min ZHAO
;
Guangyu ZHAO
;
Chunyu DAI
;
Yi ZHANG
- Publication Type:Journal Article
- Keywords:
Hypothermia;
Rectal neoplasms;
Immunity,cellular;
Thl cells;
Th2 cells
- From:
Chinese Journal of Anesthesiology
2012;32(1):24-26
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of mild pefioperative hypothermia on cellular immune function in patients undergoing surgery for rectal cancer.Methods Fifty ASA Ⅰ or Ⅱ patients aged 30-64 yr undergoing surgery for rectal cancer were randomly divided into 2 groups ( n =25 each):mild hypothermia group and normal body temperature group.Anesthesia was induced with midazolam,fentanyl,etomidate and vecuronium and maintained with propofol,remifentanil and vecuronium.The patients were mechanically ventilated after tracheal intubation.PET CO2 was maintained at 35-45 mm Hg.The venous blood samples were taken from peripheral vein at 1 h before anesthesia (T1 ),at the end of operation (T2),at 24 h after operation (T3),and on 7th day after operation (T4) to measure the serum Th1 and Th2 cytokines levels and Th1/Th2 cytokines balance was observed.Results Compared with the baseline value at T1,the serum Th2 cytokines level was significantly decreased and Th1/Th2 ratio was significantly increased at T4 in normal body temperature group,and the serum Th1 cytokines level and Th1/Th2 ratio were significantly decreased and the serum Th2 cytokines level was significantly increased at T2.3 in mild hypothermia group ( P ＜ 0.05).Compared with normal body temperature group,the serum Th1 cytokines level and Th1/Th2 ratio were significantly decreased and the serum Th2 cytokines level was significantly increased at T2-4 in mild hypothermia group ( P ＜ 0.05).Conclusion Mild perioperative hypothermia can depress cellular immune function in patients undergoing surgery for rectal cancer.
